Nephros (NEPH) insider trading
Insider activity, historical context and SEC filings · data through Nov 20, 2026
Insiders put their own money in: $15K of open-market buys. See how similar setups did below.
Label: Net buying · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.- 90-day result for Arthur H. Amron's $22K buy: in on Feb 16, 2027. See the 7- and 30-day results ↓
- Next earnings expected around Feb 8, 2027 (estimate from past release dates). Insiders usually trade in the weeks after results; past reactions ↓
Purchase Arthur H. Amron, Director bought 5,000 shares at $3.00 ($15K).
- Trade date
- Nov 16, 2026
- Disclosed to the SEC
- Nov 18, 2026
- Type
- Open-market purchase (code P)
Read the original SEC filing ↗All NEPH insider trades ↓
Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.
NEPH insider transactions (Form 4)
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Nov 18SEC | Arthur H. AmronDirectorFirst buy in 2 yrs | Buy | 5,000167,137 held (+3%) | $3.00 | $15K | -3.8% | — |
| Nov 18SEC | Arthur H. AmronDirectorFirst buy in 2 yrs | Buy | 2,500169,637 held (+1%) | $2.84 | $7K | +1.4% | — |
Similar past setups: not applicable. There aren't enough comparable past cases for NEPH's latest buying to report odds. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →
Play with NEPH in the Research Lab
Pre-set to NEPH's latest insider buy of $10K or more (Nov 18, 2026: Arthur H. Amron, $15K). Tap to change anything.
Quick backtest: did buys like this beat the market?
Tap a setting to see how 6,290 past insider buys did.
Share price and insider trades
Nephros insider trading at a glance (Nov 20, 2026): in the past 12 months, 1 insider bought $15K and 0 sold $0 of NEPH stock on the open market; P/E 16.6 vs. a sector median of 25.0.
By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings · How we calculate this
NEPH insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | $22K | 2 | — | 0 |
Valuation, profit and volume
Source: Yahoo Finance, as of Nov 19, 2026. Volume and paper profit use daily closing prices.
Summary
Over the past 12 months, 1 NEPHROS INC insider reported open-market purchases totaling $15K, while 0 insiders reported sales totaling $0.
NEPH earnings: how the stock reacted
Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.
| Release | 15 days before | Insiders, 30 days before | Reaction (2 days) | Next 30 days |
|---|---|---|---|---|
| Nov 5, 2026 | -7.7% | None | -14.2%S&P -4.1% | pending |
| Aug 6, 2026 | -0.3% | None | +17.6%S&P +0.5% | -3.6% |
| May 7, 2026 | +12.2% | None | +9.3%S&P +0.5% | -2.8% |
| Aug 11, 2025 | +13.4% | None | +9.2%S&P +0.9% | -1.2% |
| May 8, 2025 | +3.2% | None | -2.6%S&P +0.6% | +76.8% |
| Mar 6, 2025 | -3.9% | None | +13.0%S&P -1.2% | +23.6% |
| Nov 13, 2024 | +17.1% | None | -3.7%S&P -0.6% | -1.9% |
Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.
NEPH stock news and SEC filings
Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.
What happened after NEPH insiders bought
Each open-market purchase, measured from the day the filing became public, next to the S&P 500 over the same days. Losses included; "pending" means the days haven't passed yet.
| Filed | Insider | Bought | 7 days | 30 days | 90 days |
|---|---|---|---|---|---|
| Nov 18, 2026 | Arthur H. AmronDirector | $22K | pending | pending | pending |
Insiders at NEPHROS INC
| Insider | Bought | Sold | Last filing | Past buys beat S&P | Score |
|---|---|---|---|---|---|
| Arthur H. AmronDirector | $22K | — | Nov 18, 2026 | — | — |
Board links: companies that share insiders with NEPH
Directors and executives who filed Form 4s for NEPH and another company in the last 12 months.
- TUSKMammoth Energy Services Arthur H. Amron Director here · Director at TUSK · latest filing Nov 18, 2026
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
NEPH stock: common questions
Are NEPHROS INC insiders buying NEPH stock?
In the past 12 months, 1 insider reported open-market purchases of NEPH worth $15K. The latest was Director Arthur H Amron bought $15K of NEPH at $3.00 — first open-market purchase in our records.
Are NEPHROS INC insiders selling NEPH stock?
No. No NEPHROS INC insider reported an open-market sale of NEPH in the past 12 months.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is NEPH's P/E ratio?
NEPH trades at about 16.6 times trailing earnings, compared with a median of 25.0 for the Health Care sector.
What is NEPH's 52-week range?
Over the past year NEPH has traded between $2.78 and $5.79. It last closed at $2.88 on Nov 19, 2026.